Northvolt Labs, à Västerås, poursuivra le développement de cellules lithium-ion NMC à longue durée de vie et collaborera avec l’équipe de Lyten dans la Silicon Valley afin d’industrialiser la ...

(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...

Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...

The U.S. FDA granted accelerated approval for the Biologics License Application for Axogen Inc.'s Avance, an acellular nerve allograft that serves as a scaffold for nerve regrowth, for treatment of ...

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...

Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's (AXGN.O), opens new tab nerve repair graft, the health regulator said on Wednesday, paving the way for 12 years of ...

ADELAIDE, Australia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the Australia-based global CRO partner for biotechs, has been a leader in early phase clinical research for more than 30 years.

NEW YORK and MIAMI, Oct. 7, 2025 /PRNewswire/ -- Avance Investment Management ("Avance") today announced a strategic partnership with Barchemy, LLC ("Barchemy"), a leading developer and manufacturer ...

After leading the Apaches to a national championship in the spring, Micah Avance is officially the new head coach of the Tyler Junior College tennis programs. Doug Wren, athletic director, and Dr.

Avance Clinical, a partner for biotechs providing global contract research organization services, has now guided 710 emerging biotechs through critical clinical trial inflection points. Avance ...

Penny stock under ₹2: Avance Technologies share price has generated returns of 500% over a two-year period, while delivering a staggering 3,800% gain in the past five years.(Image: Pixabay) Avance ...

VANCOUVER, BC / ACCESS Newswire / August 4, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce it has entered into ...